Dr. Ashutosh Mohapatra, Founder of the Sai lnstitute of Gastroenterology and Liver Sciences located in Bhubaneswar has been successful in receiving the ‘Medical License’ from The Ministry of Justice, Govt of Japan for further enhancing and modernising the diagnosis and treatment process of Early Gastric Cancer (EGC). Here’s an exclusive coversation with Dr. Mohapatra.
Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly co-exist and can act synergistically to drive adverse outcomes.
Chronic liver disease continues to be a significant public health burden. Many people believe that only excess alcohol consumption causes liver diseases. However, a quarter of adults worldwide have non-alcoholic fatty liver disease, a condition where excess fat is stored in the liver and is more closely linked to obesity and diabetes than alcohol consumption. Most people don’t know they have non-alcoholic fatty liver disease or are at high risk for it.
Those deemed overweight or obese who drank within or above alcohol guidelines had more than a 50 per cent greater risk of developing liver disease compared to normal weight participants who consumed alcohol at the same level.
